ARVN
Arvinas Inc
Price:  
7.72 
USD
Volume:  
3,408,682.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Arvinas EV/EBITDA

-346.7%
Upside

As of 2025-09-19, the EV/EBITDA ratio of Arvinas Inc (ARVN) is -3.94. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Arvinas's latest enterprise value is 452.40 mil USD. Arvinas's TTM EBITDA according to its financial statements is -114.80 mil USD. Dividing these 2 quantities gives us the above Arvinas EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 7.7x - 15.2x 11.5x
Forward P/E multiples 12.3x - 16.0x 14.8x
Fair Price (17.67) - (22.24) (19.04)
Upside -328.9% - -388.1% -346.7%
7.72 USD
Stock Price
(19.04) USD
Fair Price

Arvinas EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-09-18 -3.94
2025-09-17 -3.87
2025-09-16 -3.89
2025-09-15 -3.95
2025-09-12 -3.95
2025-09-11 -4.00
2025-09-10 -4.01
2025-09-09 -4.12
2025-09-08 -4.08
2025-09-05 -4.01
2025-09-04 -3.87
2025-09-03 -4.06
2025-09-02 -4.06
2025-08-29 -3.95
2025-08-28 -3.97
2025-08-27 -4.17
2025-08-26 -3.83
2025-08-25 -3.79
2025-08-22 -3.68
2025-08-21 -3.67
2025-08-20 -3.54
2025-08-19 -3.57
2025-08-18 -3.59
2025-08-15 -3.54
2025-08-14 -3.53
2025-08-13 -3.54
2025-08-12 -3.35
2025-08-11 -3.21
2025-08-08 -3.03
2025-08-07 -2.99
2025-08-06 -3.12
2025-08-05 -3.87
2025-08-04 -3.82
2025-08-01 -3.75
2025-07-31 -3.76
2025-07-30 -3.85
2025-07-29 -3.79
2025-07-28 -3.87
2025-07-25 -4.02
2025-07-24 -4.05
2025-07-23 -4.04
2025-07-22 -3.85
2025-07-21 -3.81
2025-07-18 -3.70
2025-07-17 -3.97
2025-07-16 -3.86
2025-07-15 -3.74
2025-07-14 -4.04
2025-07-11 -3.99
2025-07-10 -4.05